TCTR20221106001已完成3 期
The efficacy and safety of low-dose dutasteride versus finasteride in the treatment of male androgenetic alopecia
Faculty of Medicine, Srinakharinwirot University0 个研究点目标入组 58 人开始时间: 2022年11月6日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 58
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- Male
入选标准
- •1. Male androgenetic alopecia
- •2. Age greater than or equal to 18 years old
- •3. Hamilton-Norwood classification (IIIvertex-V)
- •4. Able to follow-up
- •5. Willing to attend the project and sign informed consent form
排除标准
- •1. Past history of renal disease, hepatic disease, heart failure, benign prostatic hyperplasia
- •2. Past history of breast cancer or prostate cancer
- •3. Family history of breast cancer or prostate cancer (1st-degree relatives)
- •4. Past history of depressive disorder or suicidal attempt or 2Q and 9Q screening for depression scores greater than or equal to 7
- •5. Allergic to 5-alpha-reductase inhibitors and inactive ingredients
- •6. History of topical medications which affecting hair growth within 3 months prior eg. minoxidil, topical finasteride
- •7. History of oral medications which affecting hair growth within 6 months prior ex. dutasteride (dose greater than 1.5 mg per week), finasteride, spironolactone, ketoconazole, cyclosporine, diazoxide, cimetidine, vasodilators, steroids, chemotherapeutic agents, and antiepileptic drugs
- •8. History of shampoos or scalp serums which affecting hair growth within 1 month prior eg. ketoconazole shampoo
- •9. History of taking medicines that can cause drug interactions with medicines in this study eg. rifampicin, carbamazepine, itraconazole
- •10. Past history of other hair loss treatments within 3 months prior ex. low-level laser/light therapy or platelet-rich plasma
- •11. Past history of hair transplant
- •12. Have underlying disease that cause hair loss eg. anemia, hypothyroid or hyperthyroidism, diabetes mellitus, chronic alcoholism, and maldigestion/malabsorption
- •13. Psychiatric disorder, including trichotillomania
- •14. Eating disorder or restricted diet
- •15. Other scalp disease ex. psoriasis, seborrheic dermatitis
研究者
相似试验
尚未招募
3 期
The Efficacy of oral dutasteride in the treatment of female pattern androgenetic alopeciaAndrogenitic alopecia.IRCT20231119060107N1Tehran University of Medical Sciences40
已完成
不适用
Open labelled, single arm, interventional study of topical dutasteride lotion for androgenetic alopecia.CTRI/2022/04/041637CUTIS Academy of Cutaneous Sciences10
招募中
2 期
Efficacy and safety of low dose-steroid treatment for acute exacerbation of idiopathic interstitial pneumoniaJPRN-jRCT1061220085Takeshi Masuda11
招募中
4 期
A clinical trial to study the efficacy and safety of low dose versus standard dose emicizumab prophylaxis in haemophilia A patients.CTRI/2024/01/061593Department of Health Research, India
尚未招募
不适用
Study of absorption and elimination rate of Dutasteride capsules 0.5 mg in comparison with Dutasteride brand capsules (Avodart ®).IRCT20200407046981N33Zahravi pharmaceutical company24